Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation
Reexamination Certificate
2006-04-11
2006-04-11
Carr, Deborah D. (Department: 1621)
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Ophthalmic preparation
C554S051000, C554S064000, C514S839000, C514S840000
Reexamination Certificate
active
07025958
ABSTRACT:
The use of amidoamines to treat or prevent infections attributable toAcanthamoebaand fungi is described. The amidoamines are highly effective against bothAcanthamoebaand fungi, and are less toxic to delicate tissues that may become infected with these types of microorganisms (e.g., the cornea).
REFERENCES:
patent: 5393491 (1995-02-01), Dassanayake et al.
patent: 5573726 (1996-11-01), Dassanayake et al.
patent: 5631005 (1997-05-01), Dassanayake et al.
patent: WO 00/18386 (2000-04-01), None
Rosenthal et al., CLAO Journal, vol. 25, No. 4, pp. 213-217, Oct. 1999.
Rosenthal et al., CLAO Journal, vol. 26, No. 3, pp. 120-126, 06/872000.
Wright, et al.,Acanthamoeba Keratitis Sucessfully Treated Medically, British Journal of Ophthalmology, vol. 69, pp. 778-782 (1985).
Seal, et al.,Successful Medical Therapy of Acanthamoeba Keratitis With Topical Chlorhexidine and Propamidine, Eye, vol. 10, pp. 413-421 (1996).
Perrine, et al.,Amoebicidal Efficiencies of Various Diamidines Against Two Strains of Acanthamoeba Polyhaga, Antimicrobial Agents and Chemotherapy, vol. 39, No. 2, pp. 339-342 (1995).
Osato, et al.Cysticidal Activity of 21 Antimicrobial Agents Against 11 Corneal Isolates of Acanthamoeba, Invest. Ophthalmology Visual Science—Immunology&Microbiology—Monday AM Poster Presentation, vol. 29, p. 40 (1988).
Murdoch, et al.,Acanthamoeba Keratitis in New Zealand, Including Two Cases with In Vivo Resistance to Polyhexamethylene Biguanide, Australian and New Zealand Journal of Ophthalmology, vol. 26, pp. 231-236 (1998).
Lindquist, et al.,Clinical Signs and Medical Therapy of Early Acanthamoeba Keratitis, Arch. Ophthalmol, vol. 106, pp. 73-77 (1988).
Lindquist,Treatment of Acanthamoeba Keratitis, Cornea, vol. 17, No. 1, pp. 11-16 (1998).
Larkin, et al.,Treatment of Acanthamoeba Keratitis with Polyhexamethylene Biguanide, Ophthalmology, vol. 99, No. 2, pp. 185-191 (1992).
Kilvington, et al.,Acanthamoeba: Biology, Ecology and Human Disease, Reviews in Medical Microbiology, vol. 5, No. 1, pp. 12-20 (1994).
Ishibashi, et al.,Oral Itraconazole and Topical Miconazole with Debridement for Acanthamoeba Keratitis, American Journal of Ophthalmology, vol. 109, No. 2, pp. 121-126 (1990).
Hay, et al.,Drug Resistance and Acanthamoeba Keratitis: The Quest for Alternative Antiprotozoal Chemotherapy, Eye, vol. 8, pp. 555-563 (1994).
Gray, et al.,Acanthamoeba Keratitis: A Sobering Case and a Promising New Treatment, Australian and New Zealand Journal of Ophthalmology, vol. 22, No. 1, pp. 73-76 (1994).
Duguid, et al.,Outcome of Acanthamoeba Keratitis Treated with Polyhexamethyl Biguanide and Propamidine, Ophthalmology, vol. 104, No. 10, pp. 1587-1592 (1997).
Van Duzee, et al.,The Activity of a Multi-Purpose Solution Against Acanthamoeba, Optician, vol. 217, No. 5700, pp. 34-35 (1999).
Brasseur, et al.,Successful Treatment of Acanthamoeba Keratitis by Hexamidine, Cornea, vol. 13, No. 5, pp. 459-462 (1994).
Buck, et al.,Amoebicidal Activity of a Preserved Contact Lens Multipurpose Distinfecting Solution Compared to a Disinfection/Neutralisation Peroxide System, Contact Lens and Anterior Eye, vol. 21, No. 3, p. 81-84 (1998).
Buck, et al.,A Quantitative Method to Evaluate Neutralizer Toxicity Against Acanthamoeba Castallanii, Applied and Environmental Microbiology, vol. 62, No. 9, pp. 3521-3526 (1996).
Burger, et al.,Killing Acanthamoebae with Polyaminopropyl Biguanide: Quantitation and Kinetics, Antimicrobial Agents and Chemotherapy, vol. 38, No. 4, pp. 886-888 (1994).
Cohen, et al.,Medical and Surgical Treatment of Acanthamoeba Keratitis, American Journal of Ophthalmology, vol. 103, No. 5, pp. 615-625 (1987).
Kilvington, et al.,A Comparisoin of Cyst Age and Assay Method of the Efficacy of Contact LEns Disinfectants Against Acanthamoeba, British Journal of Ophthalmology, vol. 85, pp. 336-340 (2001).
Rosenthal, et al.,Broad Spectrum Antimicrobial Activity of a New Multi-Purpose Disinfecting Solution, The CLAO Journal, vol. 26, No. 3, pp. 120-126 (Jul. 2000).
Rosenthal, et al.,Antimicrobial Comparison of a New Multi-Purpose Disinfecting Solution to a 3% Hydrogen Peroxide System, The CLAO Journal, Vo. 25, No. 4, pp. 213-217 (Oct. 1999).
Claerhout, et al.,Acanthamoeba Keratitis: A Review; Bull. Soc. Belge Ophthalmol., vol. 274; pp. 71-82 (1999).
Korirukvongs, et al.,Treatment of Acanthameoba Keratitis with Chlorhexidine, Ophthalmology, vol. 6, No. 4, pp. 798-802 (Apr. 1999).
Tien, et al.,Treatment of Acanthamoeba Keratitis Combined With Fungal INfection with Polyhexamethylene Biguanide, Kaohsiung Journal Medical Science, vol. 15, pp. 665-673 (1999).
Gatti, et al.,In Vitro Effectiveness of Povidone-Iodine on Acanthamoeba Isolates from Human Cornea, Antimicrobial Agents and Chemotherapy, vol. 42, No. 9, pp. 2232-2234 (Sep. 1998).
Illingworth, et al.,Acanthamoeba Keratitis, Survey of Ophthalmology, vol. 42, No. 6, pp. 493-508, (Jun. 1998).
Azuara-Blanco, et al.,Successful Medical Treatment of Acanthamoeba Keratitis, International Ophthalmology, vol. 21, pp. 223-227 (1998).
Hargrave, et al.,Results of a Trial of Combined Propamidine Isethionate and Neomycin Therapy for Acanthamoebas Keratitis, Ophthalmology, vol. 106, No. 5, pp. 952-957 (May 1999).
Amoils, et al.,Acanthamoeba Keratitis with Live Isolates Treated with Cryosurgery and Fluconazole, American Journal of Ophthalmology, vol. 127, No. 6, pp. 718-720 (Jun. 1999).
Guerrero, et al.,Queratitis Por Acanthamoeba: A Proposito De Un Caso Bilateral, Farm Hospital, vol. 22, No. 5, pp. 253-255 (Feb. 1998).
Park, et al.,The Role of Topical Coricosteroids in the Management of Acanthamoeba Keratitis, Cornea, vol. 16, No. 3, pp. 277-283 (1997).
Chung, et al.,Fungal Keratitis After Laser In Situ Keratomileusis: A Case Report, Cornea, vol. 19, No. 2; pp. 236-237 (2000).
Rodriguez-Ares, et al.,Acremonium K eratitis in a Patient with Herpetifc Neurotrophic Corneal Disease, Acta Ophthalmologica Scandinavica, vol. 78; pp. 107-109; (2000).
Rahman, et al.,Trial of Chlorhexidine Gluconate for Fungal Corneal Ulcers, Ophthalmic Epidemiology, vol. 4, No. 3, pp. 141-149 (1997).
Muzyczko, et al.,Fatty Amidoamine Derivatives: N,N-Dimethyl-N-(3-alkylamidopropyl)amines and Their Salts, The Jouranl of the American Oil Chemists' Society, vol. 45, No. 11, pp. 720-725, (Nov. 1968).
Kilvington,Reducing the Risk of Microbial Keratitis in Soft Contact Lens Wearers, Optician—Contact Lens Monthly, vol. 217, pp. 28-31 (Aug. 1996).
Rahman, et al.,Randomized Trial of 0.2% Chlorhexidine Gluconate and 2.5% Natamycin for Fungal Keratitis in Bangladesh, British Journal of Ophthalmology, vol. 82 (1998) pp. 919-925.
Buck Sally L.
Dassanayake Nissanke L.
Rosenthal Ruth Ann
Schlitzer Ronald L.
Alcon Inc.
Brown Gregg C.
Carr Deborah D.
LandOfFree
Use of amidoamines to treat or prevent acanthamoeba and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of amidoamines to treat or prevent acanthamoeba and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of amidoamines to treat or prevent acanthamoeba and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616320